Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Consolidated Net Income (2022 - 2025)

Historic Consolidated Net Income for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $602.0 million.

  • GE HealthCare Technologies' Consolidated Net Income changed N/A to $602.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year increase of 16172.54%. This contributed to the annual value of -$4.0 million for FY2023, which is 12222.22% down from last year.
  • According to the latest figures from Q4 2025, GE HealthCare Technologies' Consolidated Net Income is $602.0 million.
  • Over the past 5 years, GE HealthCare Technologies' Consolidated Net Income peaked at $602.0 million during Q4 2025, and registered a low of -$4.0 million during Q3 2023.
  • In the last 4 years, GE HealthCare Technologies' Consolidated Net Income had a median value of $402.0 million in 2022 and averaged $343.3 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first crashed by 472.64% in 2023, then skyrocketed by 5154.64% in 2025.
  • GE HealthCare Technologies' Consolidated Net Income (Quarter) stood at $6.0 million in 2022, then plummeted by 166.67% to -$4.0 million in 2023, then soared by 10975.0% to $435.0 million in 2024, then soared by 38.39% to $602.0 million in 2025.
  • Its Consolidated Net Income was $602.0 million in Q4 2025, compared to $464.0 million in Q3 2025 and $500.0 million in Q2 2025.